Linked Life Data

17947722

Source:http://linkedlifedata.com/resource/pubmed/id/17947722

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
30
pubmed:dateCreated
2007-10-19
pubmed:abstractText
Malignant pleural mesothelioma (MPM) is a disease of increasing incidence for which treatment options are limited. This study reports the clinical efficacy data for vinflunine, a novel microtubule inhibitor, in MPM.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4751-6
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Phase II study of vinflunine in malignant pleural mesothelioma.
pubmed:affiliation
Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, United Kingdom. denis.talbot@cancer.org.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II